Should I snap up the soaring Boohoo share price after cracking results?

Will 2019 be the year the Boohoo Group plc (LON: BOO) share price breaks new records?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you take a look at the Boohoo Group (LSE: BOO) right now you could guess something good has just happened. It’s a top set of full-year results, and though the share price has yet to regain its previous highs of 2017, a 48% climb since the start of 2019 is certainly sending it in the right direction.

A 48% leap in revenue leading to a 49% jump in adjusted pre-tax profit is certainly impressive. Adjusted diluted EPS only rose 29%, mind, but that’s still an impressive performance. And the company ended the year with £190.7m in net cash on its books.

Big valuation

But then I turn to the stock’s fundamental valuations and I’m taken aback just a little — the shares are valued at a P/E of 58, based on that adjusted diluted EPS figure. And considering forecasts of around 5p in EPS for the coming year, we’re still looking at a multiple of 48 — and 40 the year after.

Should you invest £1,000 in Crispr Therapeutics right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Crispr Therapeutics made the list?

See the 6 stocks

This all reminds me of the fashion pioneer that blazed the trail that Boohoo now travels, ASOS (LSE: ASC), whose shares are also on sky-high valuations. ASOS shares are on an even loftier P/E of 75, based on full-year forecasts, and that’s even after the price has crashed since early 2018.

The ASOS price did pick up in early April after the company reported an 87% fall in first-half profits. If you think that sounds bizarre, I’ll hand you over to my colleague Harvey Jones to explain what happened.

Business model

I confess I didn’t grasp the ASOS business model when I first heard about it, unable to understand why people would want to buy clothing without seeing it first and trying it on. But it seems that’s not a problem — customers just order lots of stuff and send back what they don’t like and what doesn’t fit. And I can see the attraction in that.

But that approach has been turning around and biting ASOS, after the firm changed its rules to try to deal with the avalanche of returns it’s been getting. Customers returning “way more” than expected, together with those suspected of wearing items and then sending them back, could have their accounts suspended.

Though ASOS says the new rules shouldn’t affect the majority of its customers, with no explanation of how it’s deciding who to cut off, many are feeling puzzled and let down by the retailer. Some have reported being excluded without a clear explanation why.

A necessary step to reduce abuse of clothing returns? Maybe. A bad bit of customer PR? Definitely.

Pioneering problems

Will similar issues affect Boohoo? I don’t see how they can’t pose threats. Boohoo similarly needs to balance a friendly returns policy aimed at securing the loyalty of long-term customers against becoming a major force in keeping the Royal Mail in business. But if such problems do arise, Boohoo could perhaps handle them better.

These two are pioneering the online-only fashion business but, as Warren Buffett has pointed out, it’s rarely the pioneers who eventually clean up. On that thought, and considering these sky-high share price valuations, I’m not touching either.

But what does the head of The Motley Fool’s investing team think?

Should you invest £1,000 in Crispr Therapeutics right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Crispr Therapeutics made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended ASOS. The Motley Fool UK has recommended boohoo group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Dividend Shares

How a stock market crash could boost investors’ passive income by over 40%

Jon Smith explains how a continued fall in the stock market isn't always a bad thing, especially when it comes…

Read more »

Investing Articles

If an investor put £10k into Greggs shares one month ago, here’s what they’d have today

Greggs shares have had a tough year but Harvey Jones says they're notably cheaper as a result, while the dividend…

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

The Phoenix share price jumps 7.5% on today’s results, but still yields a stunning 9.4%!

Harvey Jones put his faith in the Phoenix share price and this morning was rewarded with a 7.5% jump on…

Read more »

Investing Articles

What’s been going on with the Barclays share price?

The rising Barclays share price reflects confidence in management’s strategy to improve business performance and enhance shareholder returns.

Read more »

Investing Articles

Prediction: in 1 year, the IAG share price could reach as high as…

The IAG share price has almost doubled in the last 12 months, but can this momentum continue in 2025? Zaven…

Read more »

Investing Articles

Prediction: in 12 months, here’s where the Glencore share price could be…

The performance of Glencore’s share price has been lacklustre, to say the least. But could all that change over the…

Read more »

Investing Articles

See how much an investor needs in their ISA to earn a £499 monthly second income

Harvey Jones crunches the numbers to show how it's possible to build a long-term second income by investing in a…

Read more »

Investing Articles

I’m considering buying more of this struggling FTSE 100 stock

This FTSE 100 stock hasn't exactly set our writer's portfolio on fire during the time he's owned it. But Paul…

Read more »